In response to the crisis caused by COVID-19, Eli Lilly and Company has introduced the Lilly Insulin Value Program, allowing anyone with commercial insurance and those without insurance at all to fill their monthly prescription of Lilly insulin for $35.

The program, which went into effect earlier this month, covers most Lilly insulins including all Humalog® (insulin lispro injection 100 units/mL) formulations.

“Too many people in the U.S. have lost their jobs because of the COVID-19 crisis, and we want to make sure no one goes without their Lilly insulin,” said Mike Mason, president of Lilly Diabetes. “We’ve been providing affordability solutions for a long time, but more is needed to help people during this unprecedented period. People with commercial insurance, as well as those without insurance at all, are eligible, and the process is quick and simple. We want people who need help to call us.”

The savings can be obtained by calling the Lilly Diabetes Solution Center at 833-808-1234. The Solution Center is open 8 a.m. to 8 p.m. EST, Monday through Friday.

Representatives at the Solution Center will help people with diabetes obtain a card in the most convenient way for them, including through email or the U.S. mail.

A card can typically be received within 24 hours by email. If you already have a co-pay card from the Lilly Diabetes Solution Center for an amount higher than $35, no action is necessary. Active co-pay cards have been re-set to a $35 co-pay.

Representatives at the Solution Center can also direct people to affordability options that may reduce their out-of-pocket costs further – such as free insulin for people with minimal income, or no income at all, that has been donated by Lilly to non-profit organizations.

“It’s critical that people with diabetes can reliably access insulin at a low, consistent out-of-pocket cost. Enabling a $35 per month insulin co-pay regardless of employment status will help many Americans in this difficult time,” said CEOs Aaron Kowalski and Thom Scher on behalf of the JDRF-Beyond Type 1 Alliance.

The program is one of several affordability options that can be accessed through the Solution Center. Because of federal guidelines, seniors with Medicare Part D plans are not eligible for a copay card, but they can call the Solution Center to see if they are eligible for another option, such as donated insulin for people with lower incomes or Insulin Lispro Injection (100 units/mL), a nonbranded version of Humalog U-100 with a 50 percent lower list price.

People with an urgent need for insulin and nowhere else to turn can contact the Solution Center for an immediate supply. Additionally, people with commercial insurance who use Baqsimi (glucagon) nasal powder 3 mg can pay as little as $25 for up to two devices with a co-pay card, which was first made available last summer.

For more information, call 1-800-545-5979 or go to or

WI Guest Author

This correspondent is a guest contributor to The Washington Informer.

Leave a comment

Your email address will not be published.